J.-J. Feldtrauer - Concepedia

Author

J.-J. Feldtrauer

Also Known As

Feldtrauer, Jean-François, J. -J. Feldtrauer, J. J. Feldtrauer, J.-J. FELDTRAUER, J.-J. Feldtrauer, J.J. Feldtrauer, Jean-Jacques Feldtrauer, Jean‐Jacques Feldtrauer

Publications

854

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)

About

J.-J. Feldtrauer is an author at Novartis (Switzerland) specializing in medicine, neuroscience, and neurochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	448
2	Social Sciences	9	9	369
3	Health Sciences	2	2	27
4	Metabolism	1	1	14
5	Molecular Biology	1	1	23

J.-J. Feldtrauer

Publications

828

Citations

H-Index

Page 1

	Year	Citations
Inhibition of the Mitochondrial Permeability Transition by the Nonimmunosuppressive Cyclosporin Derivative NIM811 P. C. Waldmeier, J.-J. Feldtrauer, Ting Qian, Molecular Pharmacology	2002	285
Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters P. C. Waldmeier, P. A. Baumann, Peter Wicki, Neurology NeurotransmitterPsychopharmacologySimilar PotencyPharmacotherapySocial Sciences	1995	131
GABA and glutamate release affected by GABA<sub>B</sub> receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors P. C. Waldmeier, Peter Wicki, J.-J. Feldtrauer, British Journal of Pharmacology	1994	95
Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro P.C. WaIdmeier, Peter Wicki, J.-J. Feldtrauer, Naunyn-Schmiedeberg s Archives of Pharmacology Potential InvolvementBaclofen-sensitive AutoreceptorNeurophysiologyMedicineNeurotransmitter	1988	87
CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure P. C. Waldmeier, P. A. Baumann, J.-J. Feldtrauer, Naunyn-Schmiedeberg s Archives of Pharmacology Medicinal ChemistryCgp 28014Molecular NeuroscienceFunctional SelectivityMedicine	1990	40
Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A P. C. Waldmeier, K. H. Antonin, J.-J. Feldtrauer, European Journal of Clinical Pharmacology UrologyPsychoactive DrugUrinary ExcretionMedicineForensic Toxicology	1983	29
Release of endogenous glutamate from rat cortical slices in presence of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid PeterC. Waldmeier, Peter Wicki, J.-J. Feldtrauer Naunyn-Schmiedeberg s Archives of Pharmacology NeurophysiologyMedicinePhysiologyNeurotransmitterRat Cortical Slices	1993	27
Reversibility of the interaction of CGP 11305 A with MAO A in vivo P. C. Waldmeier, J.-J. Feldtrauer, Kurt Stoecklin, European Journal of Pharmacology MedicineMao ACgp 11305Molecular BiologyPharmacology	1983	23
Weak effects of local and systemic administration of the GABA uptake inhibitor, SK&F 89976, on extracellular GABA in the rat striatum P. C. Waldmeier, K. St�cklin, J.-J. Feldtrauer Naunyn-Schmiedeberg s Archives of Pharmacology Neurobiology Of DiseaseNeurophysiologyMedicinePhysiologySystemic Administration	1992	21
The measurement of the release of endogenous GABA from rat brain slices by liquid chromatography with electrochemical detection P. C. Waldmeier, Peter Wicki, J.-J. Feldtrauer, Naunyn-Schmiedeberg s Archives of Pharmacology Neuromodulation (Medicine)Electrochemical DetectionMedicineNeurologyBrain Electrophysiology	1988	21

Page 1